跳至主要内容
临床试验/ACTRN12623000638639
ACTRN12623000638639招募中Unknown

FEBCON-ED: A stepped- wedge cluster randomised controlled clinical trial of usual care vs regular antipyretics for children presenting with a FEBrile CONvulsion to the Emergency Department.

Prof Simon Craig0 个研究点目标入组 9,600 人开始时间: 2023年6月13日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
9,600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
6 Months 至 6 Years(—)
性别
All

入选标准

  • A child with an ED diagnosis of a febrile convulsion (defined as a seizure occurring in a child without previous afebrile seizures, without significant prior neurological abnormality and without signs of central nervous system infection or metabolic disturbance) who is planned for discharge home after a period of observation from the ED or ED short stay unit.

排除标准

  • (a) a child diagnosed with a febrile convulsion who is planned to be admitted to a hospital ward;
  • (b) a child with an ED length of stay of greater than 18 hours (to allow for shorter periods of and/or overnight observation in a short-stay unit or similar setting);
  • (c) a child presenting to the ED with an afebrile convulsion;
  • (d) a child with a history of epilepsy or a history of afebrile seizures;
  • (e) a child with status epilepticus requiring at least one second-line agent (such as phenytoin or levetiracetam) to terminate their seizures;
  • (f) a child with a known allergy to both paracetamol or ibuprofen, or a medical condition in which both these medications would be contraindicated.

研究者

发起方
Prof Simon Craig

相似试验